Lord’s Mark Industry, which is actively looking to diversify into the healthcare system, is strategically expanding into the US market. The company marks this phase of expansion by acquiring its first major US order at the estimated USD 1 million; this shows how Indian MedTech designs and innovations are claiming a competitive edge globally.
This order focuses on the “Made in India” mark and concerns healthcare solutions designed, developed, and manufactured by Lord’s Mark Industries. The Indus healthcare solutions offered by Lord’s Mark are contactless remote patient monitoring (RPM) along with an AI-based early warning system (EWS). The primary function of these modernized systems identified is real-time patient monitoring, operational analytics, asynchronous electronic health records (EHR), along with true healthcare system transcendence.
This move of entering into the US market will strategically help Lord’s Mark Industries in widening its healthcare portfolio and making available its innovative SXHED to global markets. The company’s ability to secure the order also indicates the rising stature of India in the MedTech space.
AI and Contactless Monitoring: The Future of Healthcare
The request coming from the American market is the implementation of Contactless Remote Patient Monitoring (RPM) and AI-Based Early Warning Systems (EWS). These technological advancements mark a new era in preemptive and evidence-based healthcare:
- Contactless RPM: These systems offer remote monitoring of patients’ vital signs and health data without any physical interaction, thus preventing the spread of diseases.
- AI-Based EWS: AI algorithms scan through the patient’s data to forecast possible health problems, providing an opportunity for preemptive measures and, in some cases, life-saving interventions.
Global Standards: Quality and Efficacy
Lord’s Mark Industries makes it a point to mention that the company and its subsidiaries, Lord’s Mark Biotech, Lords Mark Microbiotech, and Lords Automative Private Limited, have also strived to comply with international standards for safety and efficacy. The company claims that its products are ISO 13485:2016, HIPAA, and IEC 60601-1/1-2 certified.
Drafting Shifting the Company’s Perspective: A Moment to Cherish
Sachidanand Upadhyay, Managing Director of Lords Mark Industries Ltd., noted that ‘this achievement gives me pride as well.’ In the words of Upadhyay, “This entry into the US market is an indication of our ongoing efforts at innovation and excellence.” He added that “AI-powered and contactless monitoring solutions by the company are in sync with now and the future of global healthcare,” adding at the end, “We are proud to project Indian technological prowess on the global platform.”
The Growing Conglomerate: Mark Industries
Mark Industries is not limited to working in healthcare. Founded in 1998, the firm has broadened its scope over the years and moved from working in paper to LED technology, renewable energy products, electric vehicles, genome testing, and pharmaceuticals. This diversification strategy has contributed significantly to the company’s sustainable growth and success.
Final Thoughts: MedTech Industry Brace For India
The cutting-edge MedTech solutions from Mark Industries that had garnered significant attention prior to receiving the major US order also mark a milestone in showcasing India’s strengths in these domains. It is this mark, along with his claim that India still needs to cover considerable distance to reach primary global standards in innovation and mark the latest advancement in the Indian economy.
